Efficacy of Oxfendazole in the Treatment of Trichuris Trichiura Infection in Adults
An Assessor Blind, Randomized, Comparative Study of the Efficacy of Different Doses of Oxfendazole Compared to Single Dose Albendazole in the Treatment of Trichuris Trichiura Infection in Adults
Sponsor: Oxfendazole Development Group
A PHASE2 clinical study on Trichuris Infection, this trial is actively recruiting participants. The trial is conducted by Oxfendazole Development Group and has accumulated 10 data snapshots since 2024. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Not Yet Recruiting PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting PHASE2
-
Dec 2023 — Jul 2024 [monthly]
Not Yet Recruiting PHASE2
-
Sep 2022 — Dec 2023 [monthly]
Not Yet Recruiting PHASE2
-
Oct 2021 — Sep 2022 [monthly]
Not Yet Recruiting PHASE2
▶ Show 5 earlier versions
-
Jan 2021 — Oct 2021 [monthly]
Not Yet Recruiting PHASE2
-
Oct 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE2
-
Apr 2019 — Oct 2020 [monthly]
Not Yet Recruiting PHASE2
-
Jun 2018 — Apr 2019 [monthly]
Not Yet Recruiting PHASE2
-
Mar 2018 — Jun 2018 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Oxfendazole Development Group
- Universidad Peruana Cayetano Heredia, Lima, Peru
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.